{"title":"伊朗特有棘鱼毒液抗凝和促凝组分的分离。","authors":"Nafiseh Nasri Nasrabadi, Nasser Mohammadpour Dounighi, Minoo Ahmadinejad, Hadi Rabiei, Maryam Tabarzad, Mojtaba Najafi, Hossein Vatanpour","doi":"10.5812/ijpr-127240","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The venom of <i>Echis carinatus</i> contains both procoagulant and anticoagulant components that can either promote or block the blood coagulation cascade, and some of these components affect platelet function in different ways.</p><p><strong>Objectives: </strong>The present study focuses on setting up a procedure for the purification of crude venom and designing appropriate clotting tests in order to characterize the procoagulant and anticoagulant fractions of <i>E. carinatus</i> venom.</p><p><strong>Methods: </strong>Chromatographic methods, including gel filtration, ion-exchange chromatography, and reverse-phase high-performance liquid chromatography (HPLC), were applied for purifying these fractions. Coagulant activity testing, prothrombin time (PT), and activated partial thromboplastin time (APTT) were used to determine procoagulant and anticoagulant properties. For measuring molecular weight, 15% SDS-PAGE electrophoresis with a molecular weight standard ranging from 6.5 to 200 kDa was used.</p><p><strong>Results: </strong>We obtained five fractions named F<sub>1</sub>, F<sub>2</sub>, F<sub>3</sub>, F<sub>4</sub>, and F<sub>5</sub>. The F<sub>1</sub> and F<sub>2</sub> fractions showed procoagulant activity, and the F<sub>5</sub> fraction had anticoagulant activity. The molecular weight of F<sub>2.4.2</sub> from fraction F<sub>2</sub> and F<sub>5.1</sub> from fraction F<sub>5</sub> were analyzed by SDS-PAGE electrophoresis under the reducing condition. These factors were identified as a single protein band at the end of purification. The molecular weights of these purified fractions were estimated to be 7.5 kDa and 38 kDa for F<sub>5.1(b)</sub> and F<sub>2.4.2(b)</sub>, respectively.</p><p><strong>Conclusions: </strong>Our findings suggest an efficient and suitable procedure for the identification and purification of the procoagulant and anticoagulant factors of the venom of Iranian <i>E. carinatus</i> using the PT and APTT assays.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e127240"},"PeriodicalIF":1.8000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/fa/ijpr-21-1-127240.PMC10024320.pdf","citationCount":"1","resultStr":"{\"title\":\"Isolation of the Anticoagulant and Procoagulant Fractions of the Venom of Iranian Endemic <i>Echis carinatus</i>.\",\"authors\":\"Nafiseh Nasri Nasrabadi, Nasser Mohammadpour Dounighi, Minoo Ahmadinejad, Hadi Rabiei, Maryam Tabarzad, Mojtaba Najafi, Hossein Vatanpour\",\"doi\":\"10.5812/ijpr-127240\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The venom of <i>Echis carinatus</i> contains both procoagulant and anticoagulant components that can either promote or block the blood coagulation cascade, and some of these components affect platelet function in different ways.</p><p><strong>Objectives: </strong>The present study focuses on setting up a procedure for the purification of crude venom and designing appropriate clotting tests in order to characterize the procoagulant and anticoagulant fractions of <i>E. carinatus</i> venom.</p><p><strong>Methods: </strong>Chromatographic methods, including gel filtration, ion-exchange chromatography, and reverse-phase high-performance liquid chromatography (HPLC), were applied for purifying these fractions. Coagulant activity testing, prothrombin time (PT), and activated partial thromboplastin time (APTT) were used to determine procoagulant and anticoagulant properties. For measuring molecular weight, 15% SDS-PAGE electrophoresis with a molecular weight standard ranging from 6.5 to 200 kDa was used.</p><p><strong>Results: </strong>We obtained five fractions named F<sub>1</sub>, F<sub>2</sub>, F<sub>3</sub>, F<sub>4</sub>, and F<sub>5</sub>. The F<sub>1</sub> and F<sub>2</sub> fractions showed procoagulant activity, and the F<sub>5</sub> fraction had anticoagulant activity. The molecular weight of F<sub>2.4.2</sub> from fraction F<sub>2</sub> and F<sub>5.1</sub> from fraction F<sub>5</sub> were analyzed by SDS-PAGE electrophoresis under the reducing condition. These factors were identified as a single protein band at the end of purification. The molecular weights of these purified fractions were estimated to be 7.5 kDa and 38 kDa for F<sub>5.1(b)</sub> and F<sub>2.4.2(b)</sub>, respectively.</p><p><strong>Conclusions: </strong>Our findings suggest an efficient and suitable procedure for the identification and purification of the procoagulant and anticoagulant factors of the venom of Iranian <i>E. carinatus</i> using the PT and APTT assays.</p>\",\"PeriodicalId\":14595,\"journal\":{\"name\":\"Iranian Journal of Pharmaceutical Research\",\"volume\":\"21 1\",\"pages\":\"e127240\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/fa/ijpr-21-1-127240.PMC10024320.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iranian Journal of Pharmaceutical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5812/ijpr-127240\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Pharmaceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5812/ijpr-127240","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Isolation of the Anticoagulant and Procoagulant Fractions of the Venom of Iranian Endemic Echis carinatus.
Background: The venom of Echis carinatus contains both procoagulant and anticoagulant components that can either promote or block the blood coagulation cascade, and some of these components affect platelet function in different ways.
Objectives: The present study focuses on setting up a procedure for the purification of crude venom and designing appropriate clotting tests in order to characterize the procoagulant and anticoagulant fractions of E. carinatus venom.
Methods: Chromatographic methods, including gel filtration, ion-exchange chromatography, and reverse-phase high-performance liquid chromatography (HPLC), were applied for purifying these fractions. Coagulant activity testing, prothrombin time (PT), and activated partial thromboplastin time (APTT) were used to determine procoagulant and anticoagulant properties. For measuring molecular weight, 15% SDS-PAGE electrophoresis with a molecular weight standard ranging from 6.5 to 200 kDa was used.
Results: We obtained five fractions named F1, F2, F3, F4, and F5. The F1 and F2 fractions showed procoagulant activity, and the F5 fraction had anticoagulant activity. The molecular weight of F2.4.2 from fraction F2 and F5.1 from fraction F5 were analyzed by SDS-PAGE electrophoresis under the reducing condition. These factors were identified as a single protein band at the end of purification. The molecular weights of these purified fractions were estimated to be 7.5 kDa and 38 kDa for F5.1(b) and F2.4.2(b), respectively.
Conclusions: Our findings suggest an efficient and suitable procedure for the identification and purification of the procoagulant and anticoagulant factors of the venom of Iranian E. carinatus using the PT and APTT assays.
期刊介绍:
The Iranian Journal of Pharmaceutical Research (IJPR) is a peer-reviewed multi-disciplinary pharmaceutical publication, scheduled to appear quarterly and serve as a means for scientific information exchange in the international pharmaceutical forum. Specific scientific topics of interest to the journal include, but are not limited to: pharmaceutics, industrial pharmacy, pharmacognosy, toxicology, medicinal chemistry, novel analytical methods for drug characterization, computational and modeling approaches to drug design, bio-medical experience, clinical investigation, rational drug prescribing, pharmacoeconomics, biotechnology, nanotechnology, biopharmaceutics and physical pharmacy.